Evozyne combines evolution and deep learning technology to create highly functional novel proteins - Natural Machines - to solve longstanding challenges in therapeutics and sustainability. By amplifying a protein's function based on the rules of nature, we address complex, high-impact problems. From developing life-changing patient treatments to making carbon capture a reality, Evozyne is committed to making a healthier, more sustainable world.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
09/29/23	$81,000,000	Series B	Fidelity Management & Research Company NVentures OrbiMed US Paragon Biosciences Valor Equity Partners	undisclosed